Dine Brands and Starwood Options Trading Active
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 17 2026
0mins
Should l Buy UNH?
Source: NASDAQ.COM
- Dine Brands Options Volume: Dine Brands Global Inc (Ticker: DIN) saw an options trading volume of 2,683 contracts today, representing approximately 268,300 shares, which is about 61.1% of its average daily trading volume of 439,265 shares over the past month, indicating a significant increase in market interest in the stock.
- High Call Option Activity: Among DIN's options, the $25 strike call option is particularly active, with 800 contracts traded today, representing about 80,000 shares, suggesting that investors are increasingly optimistic about the stock's future price movements, which could influence its market performance.
- Starwood Options Trading Overview: Starwood Property Trust Inc (Ticker: STWD) has recorded an options trading volume of 21,531 contracts today, equating to approximately 2.2 million shares, or 60.9% of its average daily trading volume of 3.5 million shares over the past month, reflecting sustained investor interest in the company.
- High Put Option Activity: For STWD, the $12 strike put option has seen a trading volume of 10,500 contracts today, representing around 1.1 million shares, indicating market concerns regarding potential downside risks for the company, which may affect investor sentiment and decision-making.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 324.630
Low
330.00
Averages
397.82
High
444.00
Current: 324.630
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Expectations: UnitedHealth is set to report earnings this Tuesday before market open, with market expectations indicating flat revenue year-over-year, a significant slowdown from the 9.8% growth recorded in the same quarter last year, highlighting growth challenges faced by the company.
- Revenue Performance: Last quarter, UnitedHealth reported revenues of $113.2 billion, up 12.3% year-over-year, meeting analysts' expectations; however, the full-year revenue guidance fell significantly short of analysts' forecasts, indicating uncertainty in the company's long-term growth trajectory.
- Market Sentiment: Despite UnitedHealth missing Wall Street's revenue estimates multiple times over the past two years, investor sentiment in the healthcare services sector has been positive, with average share prices rising 9.1% over the past month, while UnitedHealth's stock surged 20.2%, reflecting market optimism about its future performance.
- Analyst Views: Analysts covering UnitedHealth have generally reaffirmed their revenue estimates over the last 30 days, suggesting they expect the company to maintain stability heading into earnings, despite the pressures of slowing growth.
See More
- Payment Acceleration Program: UnitedHealthcare's Rural Payment Acceleration Pilot, launched in January 2026, reduces Medicare Advantage payment times from 30 days to under 15 days for approximately 1,500 rural hospitals, significantly enhancing cash flow and financial sustainability.
- Authorization Requirement Exemption: By fall 2026, UnitedHealthcare will exempt most medical prior authorization requirements for about 1,500 rural hospitals and their practitioners, alleviating cost and staffing pressures and allowing providers to focus more on patient care.
- Hub-and-Spoke Model: UnitedHealthcare is partnering with leading health systems to implement hub-and-spoke care models that enhance continuity of care in rural areas, focusing initially on maternity care, diabetes, and post-surgical care through advanced mobile and virtual care capabilities.
- Ongoing Investment Commitment: UnitedHealthcare is committed to further investments in rural healthcare, ensuring that these vulnerable providers receive the necessary support to deliver quality care to local residents, thereby enhancing their financial stability.
See More
- Elimination of Authorization Requirements: UnitedHealth Group has announced the end of most medical prior authorization requirements, particularly for rural providers, thereby reducing administrative burdens and enhancing service efficiency.
- Accelerated Payment Processes: The company stated that payments to rural hospitals and providers will arrive up to 50% faster, directly improving cash flow for approximately 1,500 hospitals and enhancing their operational capabilities.
- Enhanced Access to Care: Through these reforms, UnitedHealth aims to lower healthcare costs and simplify processes, significantly increasing access to quality care for individuals in rural communities, aligning with its corporate social responsibility goals.
- Promotion of Regional Healthcare Collaboration: UnitedHealth is also working with health systems to facilitate hub-and-spoke care models, connecting regional clinical experts with community-based facilities, further enhancing the accessibility and quality of healthcare services.
See More
- Positive Bank Performance: Bank stocks kicked off earnings season last week, with the State Street SPDR S&P Bank ETF (KBE) gaining over 2% and marking its fifth consecutive winning week, indicating strong market leadership and potentially boosting investor confidence.
- Focus on Defense Stocks: Jay Woods highlighted that the three largest components of the iShares U.S. Aerospace & Defense ETF (ITA)—GE, RTX, and Boeing—are set to report earnings, with ITA climbing over 7% in 2026, on track for its sixth consecutive profitable year, showcasing the strength of the defense sector.
- ServiceNow Recovery Potential: ServiceNow shares have tumbled more than 35% in 2026, making it one of the worst performers in the S&P 500, but analysts believe the sell-off is overdone, with an average price target suggesting over 72% upside, making it a stock to watch.
- UnitedHealth Stock Analysis: UnitedHealth's stock has fallen over 29% in the past year, yet it is currently trading above its 200-day moving average; Woods noted that if it holds above $324 per share, it could see upside towards $353.75, while downside risks could see it drop to $300 or $287.
See More
- Honeywell Business Sale: Honeywell sells its Productivity Solutions and Services (PSS) business to Brady Corporation for $1.4 billion in cash, a strategic move to divest cyclical, slower-growing, lower-margin operations, thereby enhancing the overall quality of its portfolio.
- Market Reaction Stable: Despite a 5% rise in oil prices due to uncertainty over commercial shipping traffic in the Strait of Hormuz, the market's decline was less severe than feared, as Treasury yields remained relatively unchanged, indicating a stable investor sentiment.
- Eli Lilly Acquisition Moves: Eli Lilly acquires clinical-stage biotech firm Kelonia Therapeutics for $3.25 billion in cash, aiming to bolster its cancer treatment pipeline, with the deal potentially worth up to $7 billion, showcasing the company's aggressive expansion strategy in oncology.
- Active IPO Market: In spite of uncertainties from the Iran conflict, Jersey Mike's confidentially files for an IPO with a valuation of approximately $8 billion, reflecting ongoing interest in new public offerings and further driving growth in investment banking activities.
See More
- Earnings Decline Expected: Analysts anticipate UnitedHealth Group's Q1 EPS to be $6.61, reflecting an 8.2% year-over-year decline, with revenue projected at $109.66 billion, only a 0.1% increase, indicating significant profitability challenges ahead.
- Estimate Revision Trends: Over the past three months, both EPS and revenue estimates have been revised downward, with EPS seeing 10 downward revisions versus 8 upward, and revenue experiencing 10 downward revisions against just 2 upward, highlighting market caution regarding the company's future performance.
- Focus on Medical Costs: Investors are likely to concentrate on medical cost trends, performance metrics from Optum, and membership growth, with management's full-year outlook being crucial, particularly the potential impact of a 2.48% increase in average Medicare Advantage payments in 2027.
- Divergent Market Sentiment: While some analysts express optimism about UnitedHealth's long-term outlook due to recent CMS rate increases and Optum restructuring, others caution that rising medical costs may continue to pressure margins, reflecting a mixed sentiment in the market.
See More











